Acción OCX ONCOCYTE CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas OncoCyte Corporation

Acciones

OCX

US68235C2061

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 20/06/2024 		Varia. Cinco días. Varia. 1 de enero.
2,87 USD +6,69 % Gráfico intradía de OncoCyte Corporation +5,13 % +14,80 %
03/06 Oncocyte Corporation anuncia resultados prometedores en un ensayo clínico de fase 2 CI
30/05 Oncocyte Corporation anuncia los resultados favorables del estudio sobre el riñón VitaGraft de OncoCyte CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
OncoCyte Names Andrea James Chief Financial Officer
Oncocyte Appoints Andrea James as Chief Financial Officer
OncoCyte Corporation Appoints Andrea James as Chief Financial Officer
OncoCyte's (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results
OncoCyte: Q1 Earnings Snapshot
Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M
OncoCyte Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
Oncocyte Reports First Quarter 2024 Financial Results
Oncocyte to Announce First Quarter 2024 Financial Results
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
OncoCyte Corporation announced that it has received $15.807655 million in funding
Broadwood Capital, Inc. Engages with OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Sector Update: Health Care Stocks Steady Pre-Bell Friday
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción OCX
  4. Noticias OncoCyte Corporation
  5. Otros idiomas